With generous support from the Independence Blue Cross Foundation under the Supporting Treatment and Overdose Prevention (STOP) program, the Medical Toxicology Foundation presents:
Curbing the Opioid Crisis in Philadelphia: Increasing Emergency Department Initiation of Buprenorphine-Naloxone for Opioid Use Disorder
This one-hour presentation, designed to educate attending physicians and medical residents on administration of buprenorphine in the emergency department (ED) for opioid overdose patients, will be offered several times throughout 2019. Buprenorphine is one of three medications approved in the United States to treat opioid addiction, it works by easing withdrawal symptoms and cravings.
Links of Interest
Articles
- ED Initiated Buprenorphine & Referral to Treatment: A Brief Guide for ED Practitioners Yale University
- Should Buprenorphine Be Administered to Patients with Opioid Withdrawal in the Emergency Department? Annals of Emergency Medicine
- Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders Journal of Hospital Medicine
- Emergency Departments — A 24/7/365 Option for Combating the Opioid Crisis New England Journal of Medicine
- Opioid Addiction Treatment article The New York Times
- USA Today article about UPenn Emergency Room program to open new paths for opioid overdose survivors
Resources
- Link to BUP 101 Algorithm of Treatment for Opioid Withdrawal
- Link to BUP 101 Powerpoint PDF
- Link to BUP 101 Treatment Programs in Philadelphia area
- ED-Bridge Emergency Buprenorphine Treatment website FAQs, stories and resources about Buprenorphine from the ED
- Link to ACMT Addiction Medicine Committee resources
Questions?
Contact info@acmt.netThe Medical Toxicology Foundation is the charitable arm of the American College of Medical Toxicology (ACMT), a nonprofit professional membership association.